Altria 2Q Profit Falls on Softer Oral-Tobacco Performance

Dow Jones
Jul 30
 

Altria Group had virtually flat revenue and lower profit in the second quarter, as lower sales of its nicotine pouches offset some of the growth in its cigarettes business.

The tobacco company on Thursday posted a profit of $2.3 billion, or $1.37 a share, compared with $2.38 billion, or $1.41 a share, a year earlier.

Stripping out certain one-time items, adjusted per-share earnings were $1.48, behind the $1.50 anticipated by analysts, according to FactSet.

Revenue was roughly flat at $6.11 billion. Analysts surveyed by FactSet forecast revenue of $5.35 billion.

Within smokeable products, which includes Marlboro and Virginia Slims cigarettes, revenue increased 0.7%. That growth was driven by higher pricing and offset partially by more promotions and lower shipment volume.

Revenue from the company's oral-tobacco business, which includes on! nicotine pouches, fell 5.3%.

Altria narrowed its full-year guidance for adjusted earnings per share to a range of $5.61 to $5.72, from a previous range of $5.56 to $5.72.

The narrowed outlook reflects Altria's expectation that it will get a greater benefit from cigarette import and export activity in the second half of the year compared with the first.

Shares were down 3.4% to $72.40 in premarket trading Thursday.

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10